Table 4. mRMR top six genes and shortest path genes KEGG enrichment.
| Term | KEGG ID | Counta | Percentageb | P-value | Benjamini Adjusted P-Value |
| Prostate cancer | 05215 | 8 | 19.5 | 3.80E-08 | 2.40E-06 |
| Pathways in cancer | 05200 | 10 | 24.4 | 2.60E-06 | 8.00E-05 |
| Wnt signaling pathway | 04310 | 6 | 14.6 | 3.00E-04 | 6.30E-03 |
| Huntington's disease | 05016 | 6 | 14.6 | 6.70E-04 | 1.10E-02 |
| Notch signaling pathway | 04330 | 4 | 9.8 | 8.80E-04 | 1.10E-02 |
| Cell cycle | 04110 | 5 | 12.2 | 1.50E-03 | 1.60E-02 |
| Insulin signaling pathway | 04910 | 5 | 12.2 | 2.00E-03 | 1.80E-02 |
| Colorectal cancer | 05210 | 4 | 9.8 | 4.70E-03 | 3.60E-02 |
| Thyroid cancer | 05216 | 3 | 7.3 | 6.20E-03 | 4.20E-02 |
| Melanogenesis | 04916 | 4 | 9.8 | 7.40E-03 | 4.60E-02 |
a
The number of genes belonging to a certain pathway.
b
The percentage of genes belonging to a certain pathway account for all the genes underwent KEGG pathway analysis.